Table 2 Major clinicopathological characteristics of MPM patients between PS and non-PS groups
From: Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome
Variables | Non-PS group (n = 86) | PS group (n = 60) | P value |
|---|---|---|---|
Gender, n (%) | 0.875 | ||
Female | 47 (54.7) | 32 (53.3) | |
Male | 39 (45.3) | 28 (46.7) | |
Age (years), n (%) | 0.873 | ||
< 60 | 57 (66.3) | 39 (65.0) | |
≥ 60 | 29 (33.7) | 21 (35.0) | |
BMI (kg/m2), n (%) | 0.156 | ||
< 18.5 | 5 (5.8) | 8 (13.3) | |
18.5–23.9 | 45 (52.3) | 34 (56.7) | |
≥ 24.0 | 36 (41.9) | 18 (30.0) | |
History of surgery, n (%) | 0.198 | ||
No | 31 (36.0) | 28 (46.7) | |
Yes | 55 (64.0) | 32 (53.3) | |
Previous surgical score, n (%) | 0.027 | ||
0/1 | 63 (73.3) | 53 (88.3) | |
2/3 | 23 (26.7) | 7 (11.7) | |
History of chemotherapy, n (%) | 0.321 | ||
No | 43 (50.0) | 25 (41.7) | |
Yes | 43 (50.0) | 35 (58.3) | |
History of radiotherapy, n (%) | 0.133 | ||
No | 86 (100.0) | 57 (95.0) | |
Yes | 0 (0.0) | 3 (5.0) | |
History of targeted therapy, n (%) | 0.049 | ||
No | 51 (59.3) | 45 (75.0) | |
Yes | 35 (40.7) | 15 (25.0) | |
KPS, n (%) | 0.035 | ||
< 80 | 6 (7.0) | 11 (18.3) | |
≥ 80 | 80 (93.0) | 49 (81.7) | |
Pathological type, n (%) | 0.880 | ||
Epithelioid type | 65 (75.6) | 46 (76.7) | |
Non-epithelioid type | 21 (24.4) | 14 (23.3) | |
Vascular tumor emboli, n (%) | 0.005 | ||
No | 73 (84.9) | 39 (65.0) | |
Yes | 13 (15.1) | 21 (35.0) | |
Lymphatic metastasis, n (%) | 0.819 | ||
No | 77 (89.5) | 53 (88.3) | |
Yes | 9 (10.5) | 7 (11.7) | |
Ki-67 index, n (%) | 0.835 | ||
≤ 9% | 14 (16.3) | 9 (15.0) | |
> 9% | 72 (83.7) | 51 (85.0) | |
Preoperative CA 125 level (U/mL), n (%) | 0.004 | ||
Normal | 35 (40.7) | 11 (18.3) | |
Increased | 51 (59.3) | 49 (81.7) | |